Logo image of BCDA

BIOCARDIA INC (BCDA) Stock Analyst Earnings Estimates

NASDAQ:BCDA - Nasdaq - US09060U6064 - Common Stock - Currency: USD

2.31  -0.11 (-4.55%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
BCDA revenue by date.BCDA revenue by date.
1.02M
580.00%
1.35M
32.35%
477K
-64.67%
93.33K
-80.43%
51K
-45.36%
51K102K
100.00%
8.568M
8,300.00%
EBITDA
YoY % growth
BCDA ebitda by date.BCDA ebitda by date.
-12.57M
18.69%
-11.82M
5.97%
-11.56M
2.20%
-9.894M
14.41%
-11.22M
-13.40%
-13.362M
-19.09%
-16.422M
-22.90%
-14.484M
11.80%
EBIT
YoY % growth
BCDA ebit by date.BCDA ebit by date.
-12.63M
18.67%
-11.9M
5.78%
-11.644M
2.15%
-8.749M
24.86%
-10.353M
-18.33%
-12.776M
-23.40%
-16.422M
-28.54%
-14.484M
11.80%
Operating Margin
BCDA operating margin by date.BCDA operating margin by date.
-1,238.24%-881.48%-2,441.09%-9,374.32%-20,300.00%-25,050.00%-16,100.00%-169.05%
EPS
YoY % growth
BCDA eps by date.BCDA eps by date.
-11.10
53.16%
-10.05
9.46%
-8.25
17.91%
-3.17
61.55%
-1.34
57.88%
-1.44
-8.02%
-1.45
-0.35%
-1.05
27.46%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
-0.64
52.78%
Revenue
Q2Q % growth
22.95K
76.54%
EBITDA
Q2Q % growth
-4.08M
-104.00%
EBIT
Q2Q % growth
-1.811M
13.12%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.61
66.11%
-1.210.6049.74%
Q2 2024
Q2Q % growth

92.00%
-0.20%
Q1 2024
Q2Q % growth
-0.09
96.47%
-0.200.1155.88%
Q4 2023
Q2Q % growth
-1.35
43.75%
-1.680.3319.79%
Q3 2023
Q2Q % growth
-1.80
29.41%
-1.840.041.96%
Q2 2023
Q2Q % growth
-2.55
-21.43%
-2.40-0.15-6.38%
Q1 2023
Q2Q % growth
-2.55
15.00%
-2.45-0.10-4.17%
Q4 2022
Q2Q % growth
-2.40
20.00%
-2.750.3512.85%
Q3 2022
Q2Q % growth
-2.55
-6.25%
-3.520.9727.54%
Q2 2022
Q2Q % growth
-2.10
30.00%
-3.791.6944.66%
Q1 2022
Q2Q % growth
-3.00
-11.11%
-3.620.6217.15%
Q4 2021
Q2Q % growth
-3.00
-33.33%
-3.170.175.50%
Q3 2021
Q2Q % growth
-2.40
46.67%
-3.210.8125.30%
Q2 2021
Q2Q % growth
-3.00
56.52%
-3.060.061.96%
Q1 2021
Q2Q % growth
-2.70
73.13%
-3.751.0527.97%
Q4 2020
Q2Q % growth
-2.25
68.75%
-4.542.2950.43%
Q3 2020
Q2Q % growth
-4.50 -4.32-0.18-4.11%
Q2 2020
Q2Q % growth
-6.90 -3.52-3.38-96.08%
Q1 2020
Q2Q % growth
-10.05 -6.27-3.78-60.21%
Q4 2019
Q2Q % growth
-7.20 -7.800.607.73%
BCDA Yearly EPS VS EstimatesBCDA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 -5 -10 -15 -20 -25
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth

-100.00%
204K-204K-100.00%
Q2 2024
Q2Q % growth
3K
-93.02%
%
Q1 2024
Q2Q % growth
60K
-6.25%
%
Q4 2023
Q2Q % growth
13K
-88.18%
96.9K-83.9K-86.58%
Q3 2023
Q2Q % growth
357K
70.00%
25.5K331.5K1,300.00%
Q2 2023
Q2Q % growth
43K
-95.57%
124.777K-81.777K-65.54%
Q1 2023
Q2Q % growth
64K
6.67%
346.8K-282.8K-81.55%
Q4 2022
Q2Q % growth
110K
37.50%
104.04K5.96K5.73%
Q3 2022
Q2Q % growth
210K
-74.39%
76.837K133.163K173.31%
Q2 2022
Q2Q % growth
970K
1,285.71%
95.88K874.12K911.68%
Q1 2022
Q2Q % growth
60K
20.00%
132.6K-72.6K-54.75%
Q4 2021
Q2Q % growth
80K
60.00%
43.605K36.395K83.47%
Q3 2021
Q2Q % growth
820K
2,633.33%
15.3K804.7K5,259.48%
Q2 2021
Q2Q % growth
70K
133.33%
22.777K47.223K207.33%
Q1 2021
Q2Q % growth
50K
25.00%
35.7K14.3K40.06%
Q4 2020
Q2Q % growth
50K
-77.27%
30.6K19.4K63.40%
Q3 2020
Q2Q % growth
30K
-84.21%
63.495K-33.495K-52.75%
Q2 2020
Q2Q % growth
30K
-66.67%
182.58K-152.58K-83.57%
Q1 2020
Q2Q % growth
40K
-81.82%
168.3K-128.3K-76.23%
Q4 2019
Q2Q % growth
220K 123.93K96.07K77.52%
BCDA Yearly Revenue VS EstimatesBCDA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2M 4M 6M 8M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS28.16% 28.16% 11.65% 38.54%
Revenue12.5% -89.77% -8.5% -81.7%